| Year |
Citation |
Score |
| 2020 |
Zhu J, Patel T, Miller JA, Torrice CD, Aggarwal M, Sketch MR, Alexander MD, Armistead PM, Coghill JM, Grgic T, Jamieson KJ, Ptachcinski JR, Riches ML, Serody JS, Schmitz JL, et al. Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients. International Journal of Molecular Sciences. 21. PMID 32013193 DOI: 10.3390/Ijms21030858 |
0.326 |
|
| 2020 |
Story C, Kuxhausen M, Spellman SR, Lee S, Paczesny S, Armistead PM, Riches ML. HLA Genotyping Does Not Predict Outcomes in Hematopoietic Cell Transplantation (alloHCT) Biology of Blood and Marrow Transplantation. 26: 73-74. DOI: 10.1016/J.Bbmt.2019.12.221 |
0.323 |
|
| 2019 |
Foster MC, Fedoriw Y, Pulley W, Zeidner J, Coombs CC, Mirkin E, Zomorrodi M, Toughiri R, Bartakova A, Carson C, Muller R, Armistead PM. Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML) Blood. 134: 1417-1417. DOI: 10.1182/Blood-2019-127434 |
0.371 |
|
| 2019 |
Muller R, Toughiri R, Bartakova A, Diaz P, Carson C, Armistead P, Fedoriw G, Foster M, Zomorrodi M, Barber-Singh J, Cheung V, Mirkin E, Melnychuk R, Fabio E, Purushotham S, et al. Abstract 4214: A microfluidic platform to capture and detect cancer cells in Leukemia patients Cancer Research. 79: 4214-4214. DOI: 10.1158/1538-7445.Sabcs18-4214 |
0.333 |
|
| 2019 |
Kasow KA, Brondon JE, Armistead PM, Serody JS, Vincent BG, Wood WA, Shea TC, Riches ML. Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients Biology of Blood and Marrow Transplantation. 25: S128-S129. DOI: 10.1016/J.Bbmt.2018.12.412 |
0.352 |
|
| 2018 |
Lansford JL, Dharmasiri U, Chai S, Hunsucker SA, Bortone DS, Keating JE, Schlup IM, Glish GL, Collins EJ, Alatrash G, Molldrem JJ, Armistead PM, Vincent BG. Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens. Blood Advances. 2: 2052-2062. PMID 30115642 DOI: 10.1182/Bloodadvances.2018022475 |
0.354 |
|
| 2017 |
Bruce DW, Stefanski HE, Vincent BG, Dant TA, Reisdorf S, Bommiasamy H, Serody DA, Wilson JE, McKinnon KP, Shlomchik WD, Armistead PM, Ting JP, Woosley JT, Blazar BR, Zaiss DM, et al. Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation. PMID 28375154 DOI: 10.1172/Jci91816 |
0.352 |
|
| 2017 |
Story CM, Lansford JL, Moore DT, Xu C, Vincent BG, Armistead PM, Riches ML. Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following Allogeneic Hematopoietic Cell Transplantation Blood. 130: 1987-1987. DOI: 10.1182/Blood.V130.Suppl_1.1987.1987 |
0.313 |
|
| 2017 |
Armistead PM, Friend R, Xenakis J, Ivanova A, Serody JS, Gabriel D, Comeau T, Sarantopoulos S, Coghill J, Wood WA, Walko CM, Rao KV, Whitley J, Shea TC. Increased Immune Suppression is Associated with Worse Overall Survival in Allogeneic Hematopoietic Cell Transplant Patients Receiving Reduced Intensity Continuous Infusion Busulfan Biology of Blood and Marrow Transplantation. 23: S261-S262. DOI: 10.1016/J.Bbmt.2016.12.158 |
0.329 |
|
| 2016 |
Attayek PJ, Hunsucker SA, Sims CE, Allbritton NL, Armistead PM. Identification and isolation of antigen-specific cytotoxic T lymphocytes with an automated microraft sorting system. Integrative Biology : Quantitative Biosciences From Nano to Macro. PMID 27853786 DOI: 10.1039/C6Ib00168H |
0.302 |
|
| 2016 |
Lansford JL, Chai S, Alatrash G, Molldrem JJ, Armistead PM, Vincent BG. Integrated In Silico Prediction of Minor Histocompatibility Antigen Peptides in HLA-Matched Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia Blood. 128: 3352-3352. DOI: 10.1182/Blood.V128.22.3352.3352 |
0.313 |
|
| 2016 |
Bruce DW, Stefanski HE, Vincent BG, Dant T, Reisdorf S, Bommiasamy H, Serody D, Wilson JE, McKinnon K, Shlomchik WD, Armistead PM, Ting JP, Woosley JT, Zaiss DM, Blazar BR, et al. Mechanism and Activity of ILC2 Cells Post Allo-BMT Blood. 128: 1155-1155. DOI: 10.1182/Blood.V128.22.1155.1155 |
0.319 |
|
| 2015 |
Jackson JM, Taylor JB, Witek MA, Hunsucker SA, Waugh JP, Fedoriw Y, Shea TC, Soper SA, Armistead PM. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. The Analyst. PMID 26523411 DOI: 10.1039/C5An01836F |
0.317 |
|
| 2015 |
Shea TC, Walko C, Chung Y, Ivanova A, Sheets J, Rao K, Gabriel D, Comeau T, Wood W, Coghill J, Armistead P, Sarantopoulos S, Serody J. Phase I/II Trial of Dose-Escalated Busulfan Delivered by Prolonged Continuous Infusion in Allogeneic Transplant Patients. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 21: 2129-35. PMID 26210442 DOI: 10.1016/J.Bbmt.2015.07.016 |
0.318 |
|
| 2015 |
Nair SV, Witek MA, Jackson JM, Lindell MA, Hunsucker SA, Sapp T, Perry CE, Hupert ML, Bae-Jump V, Gehrig PA, Wysham WZ, Armistead PM, Voorhees P, Soper SA. Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cells. Chemical Communications (Cambridge, England). 51: 3266-9. PMID 25616078 DOI: 10.1039/C4Cc09765C |
0.312 |
|
| 2015 |
Hunsucker SA, McGary CS, Vincent BG, Enyenihi AA, Waugh JP, McKinnon KP, Bixby LM, Ropp PA, Coghill JM, Wood WA, Gabriel DA, Sarantopoulos S, Shea TC, Serody JS, Alatrash G, ... ... Armistead PM, et al. Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoire. Cancer Immunology Research. 3: 228-35. PMID 25576336 DOI: 10.1158/2326-6066.Cir-14-0001 |
0.334 |
|
| 2015 |
Friend R, Xenakis J, Serody JS, Comeau T, Gabriel DA, Sarantopoulos S, Coghill J, Wood WA, Sharf A, Whitley JS, Rao K, Walko CM, Ivanova A, Shea TC, Armistead PM. Reduced Intensity Continuous Infusion Busulfan for Allogeneic Hematopoietic Cell Transplant Patients with Hematologic Disorders Who Are Ineligible or Inappropriate for Treatment with a More Intensive Therapeutic Regimen: LCCC 0306 Blood. 126: 3117-3117. DOI: 10.1182/Blood.V126.23.3117.3117 |
0.344 |
|
| 2015 |
Jackson JM, Taylor J, Witek M, Hunsucker SA, Waugh JP, Fedoriw YD, Shea TC, Soper SA, Armistead PM. Rapid Assessment of Minimal Residual Acute Myeloid Leukemia from Peripheral Blood Using a Microfluidic Chip Blood. 126: 1389-1389. DOI: 10.1182/Blood.V126.23.1389.1389 |
0.357 |
|
| 2014 |
Dickinson AJ, Hunsucker SA, Armistead PM, Allbritton NL. Single-cell sphingosine kinase activity measurements in primary leukemia. Analytical and Bioanalytical Chemistry. 406: 7027-36. PMID 24980601 DOI: 10.1007/S00216-014-7974-6 |
0.315 |
|
| 2014 |
Chow E, Rao KV, Wood WA, Covington D, Armistead PM, Coghill J, Serody JS, Gabriel DA, Jamieson KJ, Park YA, Raval JS, Shea TC. Effectiveness of an algorithm-based approach to the utilization of plerixafor in patients undergoing chemotherapy-based stem cell mobilization. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 20: 1064-8. PMID 24704385 DOI: 10.1016/J.Bbmt.2014.03.023 |
0.341 |
|
| 2013 |
Kovarik ML, Shah PK, Armistead PM, Allbritton NL. Microfluidic chemical cytometry of peptide degradation in single drug-treated acute myeloid leukemia cells. Analytical Chemistry. 85: 4991-7. PMID 23590517 DOI: 10.1021/Ac4002029 |
0.309 |
|
| 2013 |
Dickinson AJ, Armistead PM, Allbritton NL. Automated capillary electrophoresis system for fast single-cell analysis. Analytical Chemistry. 85: 4797-804. PMID 23527995 DOI: 10.1021/Ac4005887 |
0.301 |
|
| 2013 |
Lee-Sherick AB, Eisenman KM, Sather S, McGranahan A, Armistead PM, McGary CS, Hunsucker SA, Schlegel J, Martinson H, Cannon C, Keating AK, Earp HS, Liang X, DeRyckere D, Graham DK. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia. Oncogene. 32: 5359-68. PMID 23474756 DOI: 10.1038/Onc.2013.40 |
0.332 |
|
| 2013 |
Wood WA, Whitley J, Goyal R, Brown PM, Sharf A, Irons R, Rao KV, Essenmacher A, Serody JS, Coghill JM, Armistead PM, Sarantopoulos S, Gabriel DA, Shea TC. Effectiveness of etoposide chemomobilization in lymphoma patients undergoing auto-SCT. Bone Marrow Transplantation. 48: 771-6. PMID 23165501 DOI: 10.1038/Bmt.2012.216 |
0.315 |
|
| 2013 |
Zhang M, Sukhumalchandra P, Enyenihi AA, St John LS, Hunsucker SA, Mittendorf EA, Sergeeva A, Ruisaard K, Al-Atrache Z, Ropp PA, Jakher H, Rodriguez-Cruz T, Lizee G, Clise-Dwyer K, Lu S, ... ... Armistead PM, et al. A novel HLA-A*0201 restricted peptide derived from cathepsin G is an effective immunotherapeutic target in acute myeloid leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 247-57. PMID 23147993 DOI: 10.1158/1078-0432.Ccr-12-2753 |
0.354 |
|
| 2013 |
Allen JL, Tata PV, Wooten J, Fore MS, Deal AM, Sharf A, Hoffert T, Roehrs PA, Armistead PM, Coghill J, Wood WA, Shea TC, Serody J, Richards KL, Jagasia M, et al. BCR Hyper-Responsiveness In B Cells From Patients With Chronic Gvhd Is Blocked With The Syk Inhibitor R406 Blood. 122: 910-910. DOI: 10.1182/Blood.V122.21.910.910 |
0.337 |
|
| 2013 |
Dharamsiri U, Hunsucker SA, Vincent BG, Wu M, Collins EJ, Liang S, Molldrem JJ, Armistead PM. UNC-GRK4-1: An Allele Specific Cancer Testis Antigen Identified Through Genomic Screening Blood. 122: 3246-3246. DOI: 10.1182/Blood.V122.21.3246.3246 |
0.349 |
|
| 2013 |
Allen JL, Fedoriw G, Wooten J, Fore M, Roehrs PA, Armistead P, Coghill J, Shea TC, Richards K, Lee SJ, Rowe K, Rizzieri D, Chao NJ, Serody JS, Sarantopoulos S. Increased BLNK and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets Biology of Blood and Marrow Transplantation. 19: S136-S137. DOI: 10.1016/J.Bbmt.2012.11.075 |
0.303 |
|
| 2012 |
Allen JL, Fore MS, Wooten J, Roehrs PA, Bhuiya NS, Hoffert T, Sharf A, Deal AM, Armistead P, Coghill J, Gabriel DA, Irons R, Essenmacher A, Shea TC, Richards K, et al. B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways. Blood. 120: 2529-36. PMID 22896003 DOI: 10.1182/Blood-2012-06-438911 |
0.32 |
|
| 2012 |
Wood WA, Deal AM, Battaglini CL, Reeve BB, Abernethy AP, Kim YH, Whitley JS, Shatten C, Irons RN, Essenmacher AN, Wehner K, Pinto A, Coghill J, Armistead PM, Sarantopoulos S, et al. Feasibility and Prognostic Value of VO2peak in Patients Undergoing Hematopoietic Cell Transplantation (HCT) Blood. 120: 4152-4152. DOI: 10.1182/Blood.V120.21.4152.4152 |
0.326 |
|
| 2012 |
Vincent BG, Singh D, Wu M, Hunsucker SA, Alatrash G, Ruisaard K, Sukhumalchandra P, Clise-Dwyer K, Serody JS, Prins JF, Molldrem JJ, Armistead PM. RNA-Seq Expression Profiling of AML Stem Cells Reveals Differential Expression of Lineage Differentiation Markers and Novel Splice Variants. Blood. 120: 2502-2502. DOI: 10.1182/Blood.V120.21.2502.2502 |
0.304 |
|
| 2012 |
Lee-Sherick AB, Menachof K, Eisenman KM, McGranahan A, McGary C, Hunsucker SA, Schlegel J, Armistead PM, Liang X, Kireev D, Janzen W, Liu J, Stashko M, Norris-Drouin J, Earp HS, et al. Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia Blood. 120: 1317-1317. DOI: 10.1182/Blood.V120.21.1317.1317 |
0.326 |
|
| 2012 |
Walko C, Ivanova A, Whitley J, Rao K, Gabriel D, Serody J, Comeau T, Coghill J, Armistead P, Sarantopoulos S, Wood W, Shea T. Beneficial Effect of High-Dose Iv Busulfan (Bu) Delivered by Prolonged Continuous Infusion (CI) on Relapse Rate and Overall Survival (OS) in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies Biology of Blood and Marrow Transplantation. 18: S218. DOI: 10.1016/J.Bbmt.2011.12.044 |
0.315 |
|
| 2011 |
Armistead PM, Liang S, Li H, Lu S, Van Bergen CA, Alatrash G, St John L, Hunsucker SA, Sarantopoulos S, Falkenburg JH, Molldrem JJ. Common minor histocompatibility antigen discovery based upon patient clinical outcomes and genomic data. Plos One. 6: e23217. PMID 21858034 DOI: 10.1371/Journal.Pone.0023217 |
0.309 |
|
| 2011 |
McGary C, Enyenihi AA, Hunsucker SA, Ropp PA, Rodriguez-Cruz T, Lizee G, Alatrash G, Glish GL, Armistead PM. Identification of Leukemia Associated Antigens From ANKRD17 and CDK4 Using Mass Spectrometry Based Screening, Blood. 118: 4020-4020. DOI: 10.1182/Blood.V118.21.4020.4020 |
0.336 |
|
| 2011 |
Zhang M, Sukhumalchandra P, Enyenihi AA, St. John LS, Hunsucker SA, Ruisaard K, Atrache ZA, Ropp PA, Rodriguez-Cruz T, Mittendorf E, Lizee G, Clise-Dwyer K, Lu S, Glish GL, Molldrem JJ, ... Armistead PM, et al. A Novel HLA-A2 Restricted Peptide Derived From Cathepsin G Is An Effective Immunotherapeutic Target for Myeloid Leukemia Blood. 118: 2986-2986. DOI: 10.1182/Blood.V118.21.2986.2986 |
0.333 |
|
| 2011 |
Wood WA, Whitley J, Goyal RK, Brown PM, Sharf A, Irons RN, Rao K, Essenmacher AN, Serody J, Coghill J, Armistead PM, Sarantopoulos S, Gabriel DA, Shea TC. Effectiveness and Potential Strategies to Improve Outcomes Following Chemomobilization with Etoposide + G-CSF in Patients Undergoing Autologous Stem Cell Transplantation for Lymphoma Blood. 118: 2083-2083. DOI: 10.1182/Blood.V118.21.2083.2083 |
0.318 |
|
| 2011 |
Shea TC, Walko C, Ivanova A, Whitley J, Rao K, Gabriel DA, Comeau T, Coghill J, Armistead PM, Sarantopoulos S, Wood WA, Serody J. Beneficial Effect of Escalated Doses of Busulfan (BU) Delivered by Targeted Pharmacokinetics and Prolonged Continuous Infusion on Relapse Free and Overall Survival in Matched Related and Unrelated Allogeneic Transplant Patients with Hematologic Malignancies Blood. 118: 1940-1940. DOI: 10.1182/Blood.V118.21.1940.1940 |
0.306 |
|
| 2010 |
Armistead PM, Wieder E, Akande O, Alatrash G, Quintanilla K, Liang S, Molldrem J. Cyclic neutropenia associated with T cell immunity to granulocyte proteases and a double de novo mutation in GFI1, a transcriptional regulator of ELANE. British Journal of Haematology. 150: 716-9. PMID 20560965 DOI: 10.1111/J.1365-2141.2010.08274.X |
0.319 |
|
| 2010 |
Gabriel DA, Whitley J, Rao K, Horst Cvd, Serody J, Coghill J, Sarantopoulos S, Armistead P, Wood W, Shea TC. Effect of CMX001 on Levels of DNA Virus In Patients After Allogeneic Stem Cell Transplantation. Blood. 116: 4550-4550. DOI: 10.1182/Blood.V116.21.4550.4550 |
0.314 |
|
| 2010 |
Alatrash G, Ono Y, Sergeeva A, Sukhumalchandra P, Zhang M, Quintanilla K, Armistead P, He H, Rodriguez-Cruz T, Clise-Dwyer K, Wieder E, Lizee G, Lu S, Molldrem JJ. Peripheral Tolerance to PR1 Is Maintained After Uptake of Soluble Proteinas-3 and Neutrophil Elastase Blood. 116: 4301-4301. DOI: 10.1182/Blood.V116.21.4301.4301 |
0.337 |
|
| 2009 |
Armistead PM, de Lima M, Pierce S, Qiao W, Wang X, Thall PF, Giralt S, Ravandi F, Kantarjian H, Champlin R, Estey E. Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 15: 1431-8. PMID 19822303 DOI: 10.1016/J.Bbmt.2009.07.008 |
0.324 |
|
| 2008 |
Armistead PM, Mohseni M, Gerwin R, Walsh EC, Iravani M, Chahardouli B, Rostami S, Zhang W, Neuberg D, Rioux J, Ghavamzadeh A, Ritz J, Antin JH, Wu CJ. Erythroid-lineage-specific engraftment in patients with severe hemoglobinopathy following allogeneic hematopoietic stem cell transplantation. Experimental Hematology. 36: 1205-15. PMID 18550258 DOI: 10.1016/j.exphem.2008.04.004 |
0.342 |
|
| 2008 |
Armistead P, Liang S, Lu S, van Bergen CA, Falkenburg J, Molldrem JJ. Genomics as a Tool for Antigen Discovery in Allogeneic Stem Cell Transplantation: Identification of the Minor Antigen T4A through Donor/Patient Polymorphism Disparities Blood. 112: 3907-3907. DOI: 10.1182/Blood.V112.11.3907.3907 |
0.365 |
|
| 2007 |
Armistead PM, Wieder E, Akande O, Molldrem JJ. T-Cell Autoimmunity May Contribute to Neutropenia in a Patient with Cyclic Neutropenia (CN) and Double De-Novo Mutations in Gfi-1. Blood. 110: 3298-3298. DOI: 10.1182/Blood.V110.11.3298.3298 |
0.34 |
|
| 2007 |
Armistead PM, de Lima M, Pierce S, Qiao W, Wang X, Thall P, Giralt S, Champlin R, Estey E. Identifying Relapsed AML Patients Most Likely To Benefit from Allogeneic Stem Cell Transplant: A Statistical Subgroup Analysis. Blood. 110: 329-329. DOI: 10.1182/Blood.V110.11.329.329 |
0.303 |
|
| 2007 |
Armistead P, De Lima M, Pierce S, Giralt S, Champlin R, Estey E. 56: Quantifying the survival benefit of allogeneic stem cell transplant in the management of relapsed acute myeloid leukemia Biology of Blood and Marrow Transplantation. 13: 23. DOI: 10.1016/J.Bbmt.2006.12.059 |
0.309 |
|
| 2002 |
Armistead PM, Thorp HH. Electrochemical detection of gene expression in tumor samples: overexpression of Rak nuclear tyrosine kinase. Bioconjugate Chemistry. 13: 172-6. PMID 11906252 DOI: 10.1021/Bc000129Y |
0.505 |
|
| 2001 |
Armistead PM, Thorp HH. Oxidation kinetics of guanine in DNA molecules adsorbed onto indium tin oxide electrodes. Analytical Chemistry. 73: 558-64. PMID 11217762 DOI: 10.1021/Ac001286T |
0.522 |
|
| 2000 |
Armistead PM, Thorp HH. Modification of indium tin oxide electrodes with nucleic acids: detection of attomole quantities of immobilized DNA by electrocatalysis Analytical Chemistry. 72: 3764-70. PMID 10959961 DOI: 10.1021/Ac000051E |
0.535 |
|
| 1999 |
Ontko AC, Armistead PM, Kircus SR, Thorp HH. Electrochemical Detection of Single-Stranded DNA Using Polymer-Modified Electrodes. Inorganic Chemistry. 38: 1842-1846. PMID 11670956 DOI: 10.1021/Ic981211W |
0.582 |
|
| Show low-probability matches. |